v3.26.1
Stockholder's Equity - Additional Information (Details)
 1 Months Ended 12 Months Ended
Jun. 26, 2026
$ / shares
shares
Apr. 08, 2026
shares
Dec. 03, 2025
USD ($)
$ / shares
shares
Aug. 26, 2025
USD ($)
$ / shares
shares
Aug. 21, 2024
USD ($)
$ / shares
shares
Aug. 19, 2024
USD ($)
$ / shares
shares
Jun. 07, 2024
USD ($)
$ / shares
shares
Oct. 11, 2023
shares
Mar. 10, 2023
USD ($)
$ / shares
shares
Jul. 31, 2023
$ / shares
shares
Mar. 31, 2026
USD ($)
shares
$ / shares
Mar. 31, 2025
USD ($)
shares
$ / shares
Mar. 31, 2024
USD ($)
Jan. 04, 2024
$ / shares
shares
Apr. 19, 2023
shares
Disclosure of classes of share capital [line items]                              
Number of shares authorised                     2,000,000 2,000,000      
Amount of preferred investment option to an investor | $     $ 1,940,368                        
Par value per share | $ / shares                     $ 0.025 $ 0.025      
Number of shares issued                     579,218 173,679      
Net proceeds | $                     $ 2,782,707 $ 5,128,186 $ 234    
Pre-funded warrant exercise | $                     $ 705   234    
Number of shares outstanding                     579,218 173,679      
Net proceeds from exercise of warrants | $                     $ 705 $ 786,736 1,872,505    
Compensation award | $                     21,913 46,650      
Issued capital | $                     14,480 4,342      
Related party transaction payable | $                     265,982 337,576      
Fair value of the pre-funded Warrants | $     $ 2,473,390                        
Non-cash compensation expense allocated between general and administrative and research and development expenses | $                     $ 130,409 $ 365,309 $ 1,011,973    
Number of shares to be purchased by stock options issued                     8,580 8,521      
Average price | $ / shares                     $ 22 $ 17      
Fair value | $                     $ 21.5 $ 16.75      
Stock options, forfeiture                     (4,697)        
Number of stock options expired                     3,087        
Number of stock options outstanding                     17,490        
Nmber of stock options vested and exercisable                     6,430 3,495      
Private Placement Offering                              
Disclosure of classes of share capital [line items]                              
Par value per share | $ / shares     $ 0.0025                        
Net proceeds | $     $ 4,413,758                        
Placement agent fees and other offering expenses | $     $ 585,000                        
Pre-funded warrants to purchase ordinary shares     500,000                        
Ordinary shares at a purchase price per pre-funded warrant and associated preferred option | $ / shares     $ 9.9975                        
Placement Agent Warrants                              
Disclosure of classes of share capital [line items]                              
Warrant exercise price | $ / shares                 $ 91.6875            
Warrants                              
Disclosure of classes of share capital [line items]                              
Gross proceeds | $           $ 786,736                  
Offering costs | $           $ 0                  
Number of warrants exercised           10,725                  
Strike price | $ / shares           $ 73.35                  
Issuance of warrants to purchase ordinary shares     35,000                        
Fair value of warrants issued to purchase shares | $     $ 423,500                        
Incremental fair value of warrants recognized | $     $ 237,367                        
Warrants | Private Placement Offering                              
Disclosure of classes of share capital [line items]                              
Gross proceeds | $                     $ 705        
Number of warrants exercised                     282,280        
Pre-Funded Warrants                              
Disclosure of classes of share capital [line items]                              
Warrant exercise price | $ / shares     $ 0.0025                        
Number of warrants exercised                     282,280        
Issuance of warrants to purchase ordinary shares     500,000                        
Existing Warrants                              
Disclosure of classes of share capital [line items]                              
Existing warrants               29,363              
Warrant exercise price | $ / shares                 $ 200.51            
Existing warrants purchased exercised as cash                 29,363            
Net proceeds from exercise of warrants | $                 $ 1,900,000            
Incremental fair value of warrants recognized | $                 $ 579,690            
New Warrants                              
Disclosure of classes of share capital [line items]                              
Warrant exercise price | $ / shares     $ 10           $ 73.35            
Reduced exercise price | $ / shares     $ 73.35           $ 73.35            
Issuance Of Additional Warrants To Purchase Ordinary Shares     48,000                        
Incremental fair value of warrants recognized | $                 $ 3,564,786            
Events After Reporting Period                              
Disclosure of classes of share capital [line items]                              
Options issued   28,720                          
Ordinary Shares                              
Disclosure of classes of share capital [line items]                              
Par value per share | $ / shares         $ 112.5                    
Number of shares issued         44,356 10,725         579,218        
Gross proceeds | $         $ 4,990,014                    
Offering costs | $         616,339                    
Net proceeds | $         $ 4,373,675                    
Number of shares outstanding                     579,218        
Life of warrants to purchase ordinary shares         5 years                    
Issuance of warrants to purchase ordinary shares         3,105                    
Warrants issued purchase price per share | $ / shares         $ 140.75                    
Ordinary Shares | Events After Reporting Period                              
Disclosure of classes of share capital [line items]                              
Number of shares issued   217,720                          
Ordinary Shares | Purchaser | Major Ordinary Share Transactions | March Private Placement                              
Disclosure of classes of share capital [line items]                              
Number of shares issued                             9,374
Ordinary Shares | Boustead Securities, LLC                              
Disclosure of classes of share capital [line items]                              
Par value per share | $ / shares                   $ 95.00          
Shares issued for settlement of related party payable, shares                   900          
Every Ten Issued and Outstanding Ordinary Shares                              
Disclosure of classes of share capital [line items]                              
Par value per share | $ / shares                           $ 0.0001  
Every Ten Issued and Outstanding Ordinary Shares | Share Consolidation                              
Disclosure of classes of share capital [line items]                              
Par value per share | $ / shares                           $ 0.001  
Number of shares issued                           28,290  
Description of share consolidation                     Upon the effectiveness of the Share Consolidation, every ten issued and outstanding ordinary shares with a par value of US$0.0001 each was automatically consolidated into one issued and outstanding ordinary share with a par value of US$0.001 each. No fractional shares were issued as a result of the Share Consolidation. Instead, any fractional shares that would have resulted from the Share Consolidation were rounded up to the next whole number. The Share Consolidation affected all shareholders uniformly and did not alter any shareholder's percentage interest in the Company's outstanding ordinary shares, except for adjustments that may result from the treatment of fractional shares. The number of shares issued for this treatment was 28,290 shares. The Share Consolidation was approved by the Company's board of directors on November 3, 2023, and its shareholders on December 6, 2023. As such, all share and per share amounts, warrants and stock options have been given retroactive effect in the consolidated financial statements and footnotes for all periods presented.        
Number of fractional shares issued                           0  
Every Twenty Five Issued and Outstanding Ordinary Shares | Events After Reporting Period                              
Disclosure of classes of share capital [line items]                              
Par value per share | $ / shares $ 0.001                            
Every Twenty Five Issued and Outstanding Ordinary Shares | Share Consolidation                              
Disclosure of classes of share capital [line items]                              
Par value per share | $ / shares $ 0.025                            
Description of share consolidation Upon the effectiveness of the Share Consolidation, which was June 26, 2026, every twenty-five issued and outstanding ordinary shares with a par value of US$0.001 each was automatically consolidated into one issued and outstanding ordinary share with a par value of US$0.025 each. No fractional shares were issued as a result of the Share Consolidation. Instead, any fractional shares that would have resulted from the Share Consolidation were rounded up to the next whole number. The Share Consolidation affected all shareholders uniformly and did not alter any shareholder's percentage interest in the Company's outstanding ordinary shares, except for adjustments that may result from the treatment of fractional shares. The number of shares issued for this treatment was 33 shares. The Share Consolidation was approved by the Company's board of directors and shareholders on June 12, 2026. As such, all share and per share amounts, warrants and stock options have been given retroactive effect in the consolidated financial statements and footnotes for all periods presented.                            
Number of fractional shares issued 0                            
At-the-Market Offering                              
Disclosure of classes of share capital [line items]                              
Number of shares issued     35,200 88,060     15,641                
Average price of shares | $ / shares     $ 20.9375 $ 24.3225     $ 49.8275                
Gross proceeds | $     $ 737,000 $ 2,141,816     $ 779,336                
Offering costs | $     25,000 71,110     24,824                
Net proceeds | $     $ 712,000 $ 2,070,706     $ 754,511                
2022 Plan                              
Disclosure of classes of share capital [line items]                              
Number of shares authorised                     1,287        
2023 Plan                              
Disclosure of classes of share capital [line items]                              
Number of shares authorised                     3,897        
2024 Plan                              
Disclosure of classes of share capital [line items]                              
Number of shares authorised                     2,605        
2026 Plan                              
Disclosure of classes of share capital [line items]                              
Number of shares authorised                     80,000        
Top of Range | Private Placement Offering                              
Disclosure of classes of share capital [line items]                              
Preferred investment options to purchase ordinary shares     500,000                        
Top of Range | Placement Agent Warrants                              
Disclosure of classes of share capital [line items]                              
Warrants purchased                 2,056            
Top of Range | New Warrants                              
Disclosure of classes of share capital [line items]                              
Warrants purchased                 58,726            
Top of Range | 2022 Plan                              
Disclosure of classes of share capital [line items]                              
Number of shares authorised                     5,278        
Top of Range | 2023 Plan                              
Disclosure of classes of share capital [line items]                              
Number of shares authorised                     10,000        
Top of Range | 2024 Plan                              
Disclosure of classes of share capital [line items]                              
Number of shares authorised                     10,000